These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

989 related items for PubMed ID: 34837962

  • 1. LAGE3 promoted cell proliferation, migration, and invasion and inhibited cell apoptosis of hepatocellular carcinoma by facilitating the JNK and ERK signaling pathway.
    Xing Y, Liu Y, Qi Z, Liu Z, Wang X, Zhang H.
    Cell Mol Biol Lett; 2021 Nov 27; 26(1):49. PubMed ID: 34837962
    [Abstract] [Full Text] [Related]

  • 2. LINC00978 promotes hepatocellular carcinoma carcinogenesis partly via activating the MAPK/ERK pathway.
    Zhang Q, Cheng S, Cao L, Yang J, Wang Y, Chen Y.
    Biosci Rep; 2020 Mar 27; 40(3):. PubMed ID: 32077915
    [Abstract] [Full Text] [Related]

  • 3. LINC00707 promotes hepatocellular carcinoma progression through activating ERK/JNK/AKT pathway signaling pathway.
    Wang J, Luo Z, Yao T, Li W, Pu J.
    J Cell Physiol; 2019 May 27; 234(5):6908-6916. PubMed ID: 30317590
    [Abstract] [Full Text] [Related]

  • 4. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.
    Liu L, Yang X, Li NF, Lin L, Luo H.
    Cell Cycle; 2019 Nov 27; 18(21):2939-2953. PubMed ID: 31522588
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Correlation of LAGE3 with unfavorable prognosis and promoting tumor development in HCC via PI3K/AKT/mTOR and Ras/RAF/MAPK pathways.
    Li Y, Xiong H.
    BMC Cancer; 2022 Mar 21; 22(1):298. PubMed ID: 35313850
    [Abstract] [Full Text] [Related]

  • 7. Parecoxib inhibits tumorigenesis and angiogenesis in hepatocellular carcinoma through ERK-VEGF/MMPs signaling pathway.
    Tian L, Huang Y, Liu Y, Liu J, Liu Y.
    IUBMB Life; 2024 Nov 21; 76(11):972-986. PubMed ID: 38873890
    [Abstract] [Full Text] [Related]

  • 8. ERK pathway activation contributes to the tumor-promoting effects of hepatic stellate cells in hepatocellular carcinoma.
    Xie YX, Liao R, Pan L, Du CY.
    Immunol Lett; 2017 Aug 21; 188():116-123. PubMed ID: 28668554
    [Abstract] [Full Text] [Related]

  • 9. PYCR1 interference inhibits cell growth and survival via c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathway in hepatocellular cancer.
    Zhuang J, Song Y, Ye Y, He S, Ma X, Zhang M, Ni J, Wang J, Xia W.
    J Transl Med; 2019 Oct 16; 17(1):343. PubMed ID: 31619254
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Romidepsin induces G2/M phase arrest via Erk/cdc25C/cdc2/cyclinB pathway and apoptosis induction through JNK/c-Jun/caspase3 pathway in hepatocellular carcinoma cells.
    Sun WJ, Huang H, He B, Hu DH, Li PH, Yu YJ, Zhou XH, Lv Z, Zhou L, Hu TY, Yao ZC, Lu MD, Shen X, Zheng ZQ.
    Biochem Pharmacol; 2017 Mar 01; 127():90-100. PubMed ID: 28012958
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Transcription factor specificity protein 1-mediated Serine/threonine kinase 39 upregulation promotes the proliferation, migration, invasion and epithelial-mesenchymal transition of hepatocellular carcinoma cells by activating the transforming growth factor-β1 /Smad2/3 pathway.
    Wang J, Fan Z, Li J, Yang J, Liu X, Cheng J.
    Bioengineered; 2021 Dec 01; 12(1):3566-3577. PubMed ID: 34281492
    [Abstract] [Full Text] [Related]

  • 17. In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3.
    Huang S, Zhou D, Li YX, Ming ZY, Li KZ, Wu GB, Chen C, Zhao YN.
    J Cell Physiol; 2019 Apr 01; 234(4):3500-3514. PubMed ID: 30370582
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA-370 functions as a tumor suppressor in hepatocellular carcinoma via inhibition of the MAPK/JNK signaling pathway by targeting BEX2.
    Wang X, Zhu W, Xu C, Wang F, Zhu X, Sun Y, Guo Y, Fu X, Zhang Y, Zang Y.
    J Hum Genet; 2019 Dec 01; 64(12):1203-1217. PubMed ID: 31530937
    [Abstract] [Full Text] [Related]

  • 19. Modulation of IGF2BP1 by long non-coding RNA HCG11 suppresses apoptosis of hepatocellular carcinoma cells via MAPK signaling transduction.
    Xu Y, Zheng Y, Liu H, Li T.
    Int J Oncol; 2017 Sep 01; 51(3):791-800. PubMed ID: 28677801
    [Abstract] [Full Text] [Related]

  • 20. Promotion of proliferation and metastasis of hepatocellular carcinoma by LncRNA00673 based on the targeted-regulation of notch signaling pathway.
    Chen H, Liu JZ, Hu GJ, Shi LL, Lan T.
    Eur Rev Med Pharmacol Sci; 2017 Aug 01; 21(15):3412-3420. PubMed ID: 28829500
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.